A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique
单位:[1]Department of Radiation Oncology, China-Japan Friendship Hospital, Beijing, China[2]Department of Radiation Oncology, Medical School of the Chinese People’s Liberation Army (PLA), Beijing, China[3]Affiliated Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China[4]Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China[5]Department of Radiation Oncology, Armed Police Corps Hospital of Henan Province, Zhengzhou, China[6]Department of Radiation Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, China[7]Departmant of Otorhinolaryngology, First Medical Center of Chinese PLA General Hospital, Beijing, China[8]School of Data Science and Media Intelligence, Communication University of China, Beijing, China[9]State Key Laboratory of Media Convergence and Communication, Communication University of China, Beijing, China
Objective This study aimed to develop a least absolute shrinkage and selection operator (LASSO)-based multivariable normal tissue complication probability (NTCP) model to predict radiation-induced xerostomia in patients with nasopharyngeal carcinoma (NPC) treated with comprehensive salivary gland-sparing helical tomotherapy technique. Methods and Materials LASSO with the extended bootstrapping technique was used to build multivariable NTCP models to predict factors of patient-reported xerostomia relieved by 50% and 80% compared with the level at the end of radiation therapy within 1 year and 2 years, R50-1year and R80-2years, in 203 patients with NPC. The model assessment was based on 10-fold cross-validation and the area under the receiver operating characteristic curve (AUC). Results The prediction model by LASSO with 10-fold cross-validation showed that radiation-induced xerostomia recovery could be predicted by prognostic factors of R50-1year (age, gender, T stage, UICC/AJCC stage, parotid Dmean, oral cavity Dmean, and treatment options) and R80-2years (age, gender, T stage, UICC/AJCC stage, oral cavity Dmean, N stage, and treatment options). These prediction models also demonstrated a good performance by the AUC. Conclusion The prediction models of R50-1year and R80-2years by LASSO with 10-fold cross-validation were recommended to validate the NTCP model before comprehensive salivary gland-sparing radiation therapy in patients with NPC.
第一作者单位:[1]Department of Radiation Oncology, China-Japan Friendship Hospital, Beijing, China[2]Department of Radiation Oncology, Medical School of the Chinese People’s Liberation Army (PLA), Beijing, China
共同第一作者:
通讯作者:
通讯机构:[2]Department of Radiation Oncology, Medical School of the Chinese People’s Liberation Army (PLA), Beijing, China[6]Department of Radiation Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, China[8]School of Data Science and Media Intelligence, Communication University of China, Beijing, China[9]State Key Laboratory of Media Convergence and Communication, Communication University of China, Beijing, China
推荐引用方式(GB/T 7714):
Teng Feng,Fan Wenjun,Luo Yanrong,et al.A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique[J].FRONTIERS in ONCOLOGY.2021,11:doi:10.3389/fonc.2021.633556.
APA:
Teng, Feng,Fan, Wenjun,Luo, Yanrong,Xu, Shouping,Gong, Hanshun...&Ma, Lin.(2021).A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique.FRONTIERS in ONCOLOGY,11,
MLA:
Teng, Feng,et al."A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique".FRONTIERS in ONCOLOGY 11.(2021)